Skip to main contentSkip to breadcrumbsSkip to sub navSkip to doormat

Intratumoral hu14.18-IL2 combination immunotherapy, to activate innate and adaptive immunity as an in situ vaccine

Intratumoral hu14.18-IL2 combination immunotherapy, to activate innate and adaptive immunity as an in situ vaccine


  • 13:00
  • IMBA/GMI Lecture Hall
  • Paul Sondel
Institute:
University of Wisconsin School of Medicine and Public Health
Type:
Impromptu Seminar
Location:
IMBA/GMI Lecture Hall